ClinicalTrials.Veeva

Menu

Autologous Fat Infiltration Versus General Measures as Treatment in Radiodermatitis Induced for Radiotherapy in Breast Cancer Patients

I

Instituto Mexicano del Seguro Social

Status

Completed

Conditions

Breast Cancer
Radiotherapy
Radio Dermatitis

Treatments

Procedure: Autologous fat filtration

Study type

Interventional

Funder types

Other

Identifiers

NCT07023796
R-2023-1301-147

Details and patient eligibility

About

Radiodermatitis is a major problem in oncologic patients, fat grafts previously used for cosmetic procedures have been shown to have regenerative power due to their stem cell content. Our purpose was to compare the clinical changes in the treatment of radiation dermatitis in breast cancer patients with the application of fat graft versus traditional therapy with general measures.A randomized controlled clinical trial was performed, 22 patients were recruited and randomly assigned to one of two groups: an intervention group that received an autologous fat graft and a control group that received treatment with general measures; a 6-week follow-up was performed to determine the presence and classification of radiodermatitis using the LENT/SOMA scales, as well as biopsies. Women were included, with a diagnosis of breast cancer, Eastern Cooperative Oncology Group 0 or 1, attended in our hospital during September 2023 to October 2024, older than 18 years, undergoing lumpectomy or mastectomy and in radiotherapy as part of the treatment scheme for breast cancer.

Enrollment

22 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients older than 18 years with a confirmed diagnosis of common bile duct cyst by imaging studies and/or intraoperative findings.
  • Patients who received surgical treatment at the institution during the study period.
  • Clinical records with complete information for analysis.

Exclusion criteria

  • Patients who do not consent to their inclusion in the study or who for any physical or mental reason are unable to give their consent (patients with cognitive impairment, etc.).
  • Pediatric patients (<18 years).
  • Incomplete clinical records or with loss of postoperative follow-up.
  • Patients with diagnosis of other biliary pathology without evidence of common bile duct cyst.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

22 participants in 2 patient groups

Patients who received general care
No Intervention group
Description:
Patients who received daily skin washing with warm water and mild soap (pH neutral, fragrance free) without scrubbing.
Patients who received autologous fat filtration
Active Comparator group
Description:
Patients who underwent a surgical procedure and autologous fat processing for subsequent fat filtration.
Treatment:
Procedure: Autologous fat filtration

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems